Bogenberger, J. M., Delman, D., Hansen, N., Valdez, R., Fauble, V., Mesa, R. A., & Tibes, R. (2014). Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies. Leuk Lymphoma.
Styl ChicagoBogenberger, James M., Devora Delman, Nanna Hansen, Riccardo Valdez, Veena Fauble, Ruben A. Mesa, a Raoul Tibes. "Ex Vivo Activity of BCL-2 Family Inhibitors ABT-199 and ABT-737 Combined With 5-azacytidine in Myeloid Malignancies." Leuk Lymphoma 2014.
Citace podle MLABogenberger, James M., et al. "Ex Vivo Activity of BCL-2 Family Inhibitors ABT-199 and ABT-737 Combined With 5-azacytidine in Myeloid Malignancies." Leuk Lymphoma 2014.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..